255 related articles for article (PubMed ID: 11205211)
1. Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents.
Kops SP
Anticancer Res; 2000; 20(6C):4745-9. PubMed ID: 11205211
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for SV40 in human cancer?
Poulin DL; DeCaprio JA
J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
[TBL] [Abstract][Full Text] [Related]
3. Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.
Sierra-Honigmann A; Krause PR
Biologicals; 2000 Mar; 28(1):1-4. PubMed ID: 10799049
[TBL] [Abstract][Full Text] [Related]
4. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
Cutrone R; Lednicky J; Dunn G; Rizzo P; Bocchetta M; Chumakov K; Minor P; Carbone M
Cancer Res; 2005 Nov; 65(22):10273-9. PubMed ID: 16288015
[TBL] [Abstract][Full Text] [Related]
5. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
6. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines.
Hirvonen A; Mattson K; Karjalainen A; Ollikainen T; Tammilehto L; Hovi T; Vainio H; Pass HI; Di Resta I; Carbone M; Linnainmaa K
Mol Carcinog; 1999 Oct; 26(2):93-9. PubMed ID: 10506753
[TBL] [Abstract][Full Text] [Related]
7. Examination of poliovaccines for the presence of SV40 sequences.
Sangar DV; Wood DJ; Minor PD
Dev Biol Stand; 1998; 94():221-5. PubMed ID: 9776243
[TBL] [Abstract][Full Text] [Related]
8. Examination of poliovirus vaccine preparations for SV40 sequences.
Sangar D; Pipkin PA; Wood DJ; Minor PD
Biologicals; 1999 Mar; 27(1):1-10. PubMed ID: 10441397
[TBL] [Abstract][Full Text] [Related]
9. Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests.
Butel JS
Bull World Health Organ; 2000; 78(2):195-8. PubMed ID: 10743284
[TBL] [Abstract][Full Text] [Related]
10. SV40 and human brain tumors.
Geissler E; Staneczek W
Arch Geschwulstforsch; 1988; 58(2):129-34. PubMed ID: 2837160
[TBL] [Abstract][Full Text] [Related]
11. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
Olin P; Giesecke J
Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk associated with simian virus 40 contaminated polio vaccine.
Fisher SG; Weber L; Carbone M
Anticancer Res; 1999; 19(3B):2173-80. PubMed ID: 10472327
[TBL] [Abstract][Full Text] [Related]
13. Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection.
Rizzo P; Di Resta I; Powers A; Ratner H; Carbone M
Cancer Res; 1999 Dec; 59(24):6103-8. PubMed ID: 10626798
[TBL] [Abstract][Full Text] [Related]
14. Public health. Creeping consensus on SV40 and polio vaccine.
Ferber D
Science; 2002 Oct; 298(5594):725-7. PubMed ID: 12399560
[No Abstract] [Full Text] [Related]
15. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
16. Product quality control testing for the oral polio vaccine.
Brock B; Kelleher L; Zlotnick B
Dev Biol Stand; 1998; 94():217-9. PubMed ID: 9776242
[TBL] [Abstract][Full Text] [Related]
17. Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer.
Engels EA; Chen J; Viscidi RP; Shah KV; Daniel RW; Chatterjee N; Klebanoff MA
Am J Epidemiol; 2004 Aug; 160(4):306-16. PubMed ID: 15286015
[TBL] [Abstract][Full Text] [Related]
18. SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.
Magnani C
Med Lav; 2005; 96(4):347-53. PubMed ID: 16457431
[TBL] [Abstract][Full Text] [Related]
19. Tests fail to support claims for origin of AIDS in polio vaccine.
Dickson D
Nature; 2000 Sep; 407(6801):117. PubMed ID: 11001021
[No Abstract] [Full Text] [Related]
20. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.
Engels EA
Expert Rev Vaccines; 2005 Apr; 4(2):197-206. PubMed ID: 15889993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
